Abstract
We report a case of sudden unexpected death in an adult woman from florid myocarditis with necrosis, replacement fibrosis, and diffuse infiltration of the myocardium by eosinophils and conspicuous giant cells. Clinical history revealed that 3 weeks prior to death, shortly after commencing antibiotic therapy for the treatment of traumatic wound of a finger, she presented to the emergency room with a hypersensitivity reaction characterized by facial rash with edema and generalized pruritus. She was treated with antihistamines and discharged. The clinico-pathological correlation suggests a link between drug hypersensitivity and the giant cell myocarditis.
References
Blauwet LA, Cooper LT. Myocarditis. Prog Cardiovasc Dis. 2010;52:274–88.
Baughman KL. Diagnosis of myocarditis: death of Dallas criteria. Circulation. 2006;113:593–5.
John JJF, Hugh AAM, Mullick FG. Drug related myocarditis: I. Hypersensitivity myocarditis. Hum Pathol. 1981;12:900–7.
Ishikawa H, Kaneko H, Watanabe H, et al. Giant cell myocarditis in association with drug-induced skin eruption. Acta Pathol Jpn. 1987;37:639–44.
Daniels PR, Berry GJ, Tazelaar HD, Cooper LT. Giant cell myocarditis as a manifestation of drug hypersensitivity. Cardiovasc Pathol. 2000;9:287–91.
Adachi Y, Yasumizu R, Hashimoto F, et al. An autopsy case of giant cell myocarditis probably due to a non-steroidal anti-inflammatory drug. Pathol Int. 2001;51:113–7.
French AJ, Weller CV. Interstitial myocarditis following the clinical and experimental use of sulfonamide drugs. Am J Pathol. 1942;18:109–21.
Lewis W, Silver MD. Adverse effects of drugs on the cardiovascular system. In: Silver MD, Gotlieb AI, Schoen FJ, editors. Cardiovascular pathology. New York: Churchill Livingston; 2001. p. 541–61.
Taliercio CP, Olney BA, Lie JT. Myocarditis related to drug hypersensitivity. Mayo Clin Proc. 1985;60:463–8.
Winters GL, McManus BM. Myocarditis. In: Silver MD, Gotlieb AI, Schoen FJ, editors. Cardiovascular pathology. New York: Churchill Livingston; 2001. p. 256–84.
Burke AP, Saenger J, Mullick F, Virmani R. Hypersensitivity myocarditis. Arch Pathol Lab Med. 1991;115:764–9.
Cooper LT Jr. Myocarditis. N Engl J Med. 2009;360:1526–38.
Herzog CA, Snover DC, Staley NA. Acute necrotising eosinophilic myocarditis. Br Heart J. 1984;52:343–8.
Getz MA, Subramanian R, Logemann T, Ballantyne F. Acute necrotizing eosinophilic myocarditis as a manifestation of severe hypersensitivity myocarditis. Antemortem diagnosis and successful treatment. Ann Intern Med. 1991;115:201–2.
Cooper LT Jr, Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis—natural history and treatment. N Engl J Med. 1997;336:1860–6.
Davies MJ, Pomerance A, Teare RD. Idiopathic giant cell myocarditis–a distinctive clinico-pathological entity. Br Heart J. 1975;37:192–5.
Cooper LT Jr. Giant cell myocarditis: diagnosis and treatment. Herz. 2000;25:291–8.
Cihakova D, Rose NR. Pathogenesis in Myocarditis and Dilated cardiomyopathy. In: Alt FW, editor. Advances in immunology. Amsterdam: Elsevier Inc; 2008. p. 95–114.
Kodama M, Matsumoto Y, Fujiwara M, et al. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clinical Immunol Immunopathol. 1990;57:250–62.
Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med. 2003;139:683–93.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martinez, S., Miranda, E., Kim, P. et al. Giant cell myocarditis associated with amoxicillin hypersensitivity reaction. Forensic Sci Med Pathol 9, 403–406 (2013). https://doi.org/10.1007/s12024-013-9418-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12024-013-9418-6